주식/증권 ➡️ 중립 ResMed expects FY 2027 revenue of $5.75B-$5.85B and non-GAAP EPS of $12-$12.25 while accelerating $1.85B+ shareholder returns Seeking Alpha - Market News 2026/08/07 01:55:04 4회 원문 기사 보기